Captrust Financial Advisors Harmony Biosciences Holdings, Inc. Transaction History

Captrust Financial Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$33.54 - $52.15 $9,324 - $14,497	278 Added 180.52%	432 $21,000
Q1 2022 May 16, 2022	SELL	$33.14 - $51.13 $861 - $1,329	-26 Reduced 14.44%	154 $7,000
Q4 2021 Feb 14, 2022	BUY	$34.09 - $43.91 $5,829 - $7,508	171 Added 1900.0%	180 $8,000
Q2 2021 Aug 16, 2021	BUY	$25.96 - $33.44 $233 - $300	9 New	9 $0

242

45.2M

108K

49.2K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.02B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.